Skip to main content

Table 4 Multivariate Analysis of Overall Survival

From: Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects

Variable

Hazard ratio (95 % Cl)

p value

No. of metastatic/recurrent lesions (1–2)

0.453 (0.152–1.240)

0.155

Oligo-recurrence group

0.253 (0.082–0.843)

0.035

Adenocarcinoma

0.496 (0.211–1.164)

0.107

KPS score (90–100)

0.330 (0.120–1.066)

0.064

Interval to brain recurrence, ≥12 months

1.158 (0.509–2.636)

0.726

RPA (class I)

1.319 (0.556–3.071)

0.521

Thoracic stage a (I–II)

1.544 (0.777–3.066)

0.215

  1. Abbreviations: KPS Karnofsky performance status, RPA recursive partition analysis
  2. aThoracic stage is classified according to the TNM classification of malignant tumors version 6 (UICC, Union for International Cancer Control version 6 edition) not evaluating M stage